about
Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamilyThe human natural killer gene complex is located on chromosome 12p12-p13The linker region joining the catalytic and the regulatory domains of CnA is essential for binding to NFAT.Cyclooxygenase-2: a therapeutic target in angiogenesis.Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology.IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritisThe RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines.Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc-/- mice.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1.Display of the albumin binding domain in the envelope improves lentiviral vector bioavailability.NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis.The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I moleculesThe NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia modelThe sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunitBlockade of NFAT activation by the second calcineurin binding siteIntratumoral expression using a NFkB-based promoter enhances IL12 antitumor efficacy
P50
Q24314332-371B558A-5048-45DE-A13A-5C2A21790652Q28243367-D345F545-2FB4-4D5F-8665-CFF4E6A8B464Q34388233-2C2B865B-6E0A-4E39-A62A-9AFB611D1B30Q35077006-DDC62DB4-579F-4DD8-858A-FE034A93CFFAQ35695531-19EC6163-5DFE-4A57-92FF-F7CF7A91E2ADQ36512506-F78AF1B3-75BD-4AD7-9D1C-024806A676A5Q37158993-E5B6E2D1-7127-4D49-A21F-BA0ED5A6261FQ38829316-D46A0B9E-AFD2-460E-86AF-15408DF2E046Q40560385-37289392-4D33-41FA-A098-FE9E19E467B7Q40615752-13E405AB-089B-47F8-9DB4-55153E07BABDQ43769847-C8E3344D-339F-4F41-882F-B6F62793E6F0Q43847020-E7F66644-A508-4374-9ABB-4B821DD76D4BQ44184963-980EF8DA-8A8D-49AA-A059-482FFBE88A72Q45874827-140ED1A9-B053-4E05-903B-955E69D7D00BQ53242935-9D380E5C-AFF7-463F-A770-AFDA1E4A2473Q57200941-732CEBDF-08CB-4EBC-9EFF-02AE91008639Q58063547-EAD92B4E-1E7A-45E1-A4CC-973319481324Q81850030-DEE77B39-07FB-4F03-838A-CE765C91E23BQ82238797-AC32A474-25C7-403C-BEB4-7D6C727DF035Q90950102-2F567858-69DF-48ED-9E07-87DAB141831C
P50
description
Forscher
@de
investigador
@es
onderzoeker
@nl
researcher
@en
ricercatore
@it
研究員
@ja
研究者
@zh
name
Antonio Andres Rodríguez
@en
Rodríguez A
@nl
type
label
Antonio Andres Rodríguez
@en
Rodríguez A
@nl
altLabel
Antonio Andres Rodriguez Marquez
@en
prefLabel
Antonio Andres Rodríguez
@en
Rodríguez A
@nl
P108
P106
P108
P31
P496
0000-0003-2455-6583